Therapeutic effect of activated ZEB1 on steroid-induced femoral head necrosis
By activating ZEB1 and regulating the Wnt/β-catenin signaling pathway, the coupling of H-type blood vessels and angiogenesis is promoted, and the problem of unknown effect of H-type blood vessels in hormonal femoral head necrosis is solved, and effective treatment of femoral head necrosis is achieved.
Patent Information
- Application Number
- CN202411232708.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art has not yet clarified the role of H-type blood vessels in hormonal femoral head necrosis and their treatment methods, resulting in insufficient effective means of treating femoral head necrosis.
By activating ZEB1, gene knockdown and cationic liposome transfection techniques are used to regulate the Wnt/β-catenin signaling pathway in mouse models, promoting the osteogenesis of H-type blood vessels and vascular vessels, and then exploring its treatment of femoral head necrosis effect.
By highly expressing ZEB1 in femoral head H-type vascular endothelial cells, the Wnt/β-catenin pathway is regulated, which significantly improves the therapeutic effect of femoral head necrosis, providing new treatment ideas and methods.
Smart Images

Figure CN119015424A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of treatment of femoral head necrosis, and particularly relates to the therapeutic effect of activated ZEB1 on hormone-induced femoral head necrosis. Background Art
[0002] Bone is a highly vascularized tissue. In the mammalian skeletal system, osteogenesis and angiogenesis play an important role in bone growth, development, regeneration and reconstruction. Blood vessels not only provide bone tissue with abundant oxygen, nutrients, growth factors and necessary hormones, but have recently been found to play an important role in regulating bone formation. The capillaries in bone tissue are divided into two types: H-type vessels and L-type vessels according to the expression of markers and functions.
[0003] Femoral head necrosis is a disabling disease caused by the destruction of the blood supply to the femoral head, which leads to ischemia, necrosis and collapse of the femoral head. H-type blood vessels are commonly found near the growth plate of the epiphyseal end, in the periosteum and endosteal structures, which can closely integrate the angiogenesis and osteogenesis in the bone, thereby inducing and promoting bone formation. Previous studies have confirmed that the increase of H-type blood vessels can improve osteoporosis and promote the healing of bone defects. However, its role in the onset of femoral head necrosis is still unclear.
[0004] Therefore, this study aims to explore the role of H-type blood vessels in the occurrence, development and treatment of steroid-induced femoral head necrosis, so as to provide new ideas and methods for its treatment. Summary of the invention
[0005] The purpose of the present invention is to provide a therapeutic effect of activated ZEB1 on hormone-induced femoral head necrosis to solve the problems raised in the above-mentioned background technology.
[0006] To achieve the above object, the present invention provides the following technical solution: activating ZEB1 for the treatment of steroid-induced femoral head necrosis, comprising the following steps:
[0007] S1: Collection: Femoral heads of SONFH and femoral neck fracture patients were collected and decalcified for immunofluorescence staining to compare the expression of ZEB1 and H-type blood vessels in the femoral heads of SONFH patients and femoral neck fracture patients;
[0008] S2: Model construction: construct a SONFH mouse animal model and set up a blank control group;
[0009] S3: Detection: Based on the successful construction of the SONFH mouse model, cationic liposome transfection technology was used to overexpress ZEB1 in SONFH mice to further detect the expression of ZEB1, H-type blood vessels, angiogenic and osteogenic ability, and Wnt / β-catenin signaling pathway.
[0010] It should be noted in the protocol that in step S2, based on the successful construction of the SONFH mouse model, lentiviral infection technology was used to knock down ZEB1, so as to further detect the expression of ZEB1, H-type blood vessels, vascular osteogenic coupling levels and Wnt / β-catenin signaling pathway.
[0011] Compared with the prior art, the therapeutic effect of activated ZEB1 provided by the present invention on hormone-induced femoral head necrosis is rationally grouped by using technical interventions such as gene knockdown and liposome transfection of animals, and the expression of ZEB1, Wnt, Runx2 / Osterix / ALP, VEGF, H-type vascular endothelial cell CD31, and EMCN are located and quantitatively analyzed by immunofluorescence double labeling and multiple labeling techniques. The above techniques and methods confirm that ZEB1 is highly expressed in H-type vascular endothelial cells of the femoral head, and the therapeutic effect of ZEB1 on femoral head necrosis by regulating the Wnt / β-catenin pathway to mediate vascular-osteogenic coupling is clarified. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 The expression of ZEB1 molecules and H-type blood vessels in the steroid-induced femoral head necrosis group and the femoral neck fracture group. DETAILED DESCRIPTION
[0013] The present invention will be further described below in conjunction with the embodiments.
[0014] See also Figure 1 The present invention provides a therapeutic effect of activating ZEB1 on hormone-induced femoral head necrosis, comprising the following steps:
[0015] S1: Collection: Femoral heads of SONFH and femoral neck fracture patients were collected and decalcified for immunofluorescence staining to compare the expression of ZEB1 and H-type blood vessels in the femoral heads of SONFH patients and femoral neck fracture patients;
[0016] S2: Model construction: A SONFH mouse model was constructed and a blank control group was set up. Based on the successful construction of the SONFH mouse model, ZEB1 was knocked down using lentiviral infection technology to further detect the expression of ZEB1, H-type blood vessels, vascular osteogenic coupling levels, and the Wnt / β-catenin signaling pathway;
[0017] S3: Detection: Based on the successful construction of the SONFH mouse model, cationic liposome transfection technology was used to overexpress ZEB1 in SONFH mice to further detect the expression of ZEB1, H-type blood vessels, angiogenic and osteogenic ability, and Wnt / β-catenin signaling pathway.
[0018] Example:
[0019] Bone is a highly vascularized tissue. In the mammalian skeletal system, osteogenesis and angiogenesis play an important role in bone growth, development, regeneration and reconstruction. Blood vessels not only provide bone tissue with abundant oxygen, nutrients, growth factors and necessary hormones, but have also recently been found to play an important role in regulating bone formation. The capillaries in bone tissue are divided into H-type vessels and L-type vessels according to marker expression and function. The endothelial cells of H-type capillaries strongly express endomucin (EMCN) and platelet endothelial cell adhesion molecule (PECAM). molecule-1, PECAM-1 / CD31), marked by: CD31hiEMCNhi vascular endothelial cells, which can closely integrate the blood vessels in the bone with the osteoblasts, thereby inducing and promoting osteogenesis, while the L-type blood vessels lowly express CD31 and EMCN. Although they are also surrounded by hematopoietic cells and connected to the large central vein, the arterioles only transport blood to the H-type blood vessels attached to the metaphyseal growth plate instead of the L-type blood vessels. The H-type blood vessels are most abundant in young and growing animals, and are commonly found near the growth plate of the metaphyseal end, the periosteum and the endosteal structure. They are basically undetectable in non-bone tissues. They are a key component of the bone microenvironment. Because the blood flows through the H-type blood vessels first, it obtains nutrients and oxygen first, thereby promoting the expression of pre-osteoprogenitor cells with high expression of Runt-related transcription factor 2 (Runx2) and high expression of osteoblast-related transcription factor antibody Osterix (Osterix relatedtranscription The molecular crosstalk is widely present among osteoblasts, osteoclasts and endothelial cells. In the whole process of embryonic development and bone growth and healing, the temporal and spatial connection between angiogenesis and osteogenesis is particularly close: in terms of time, angiogenesis is earlier than osteogenesis.From a spatial perspective, the vast majority of osteoblasts are distributed around H-type vessels during bone healing. This close connection between angiogenesis and osteogenesis in time and space is named "vascular-osteogenesis coupling". With the deepening of research, more and more scholars have found that the decline in the number of bone H-type vessels is related to the occurrence of many diseases. Wang et al. found that the abundance of human H-type vessels and osteoprogenitor cells may be related to changes in bone microstructure and late osteopenia, indicating that the number of H-type vessels is an important manifestation of early bone loss, and proposed a method to treat osteoporosis by intervening in H-type vessels. Similarly, researchers have found that enhanced proosteoclast platelet-derived growth factor BB reduces hormone-induced osteoporosis by protecting H-type vessels and osteoblasts. Therefore, the reduction or dysfunction of H-type vascular endothelial cells in the bone may be closely related to the progression of femoral head necrosis, and intervention to restore the expression level and function of H-type vascular endothelial cells in the bone, thereby promoting angiogenesis-dependent osteogenesis, may play a role in the treatment of hormone-induced femoral head necrosis. ;
[0020] Wnt is a secretory glycoprotein containing an N-terminal signal peptide for secretion. It controls the development and generation of blood vessels by acting on vascular endothelial cells. For example, some researchers have found that in normal oxygen-containing gliomas, angiogenesis can be promoted by activating the Wnt / β-catenin pathway. The Wnt pathway is not only closely related to angiogenesis, but also can activate the transcriptional expression of downstream target genes to regulate the occurrence of osteogenesis. Some researchers have pointed out that the angiogenic factor EGFL6 can act on the vascular endothelium and BMSCs through the Wnt / β-catenin signaling pathway to regulate angiogenesis and osteogenesis. Similar studies suggest that Wn can be activated by knocking out Foxf1. t / β-catenin signaling pathway, thereby reducing bone loss in the osteoporosis model of mice after ovariectomy. Studies have shown that the osteogenic differentiation ability of BMSCs in the necrotic area of the femoral head is significantly lower than that in the non-necrotic area, GSK-3β is significantly increased, while the key osteogenic molecules Runx2 and β-catenin are significantly decreased, indicating that the Wnt / β-catenin signaling pathway in BMSCs in the necrotic area is damaged. However, it is not clear how the activity of the Wnt / β-catenin signaling pathway is strictly controlled in bone H-type vascular endothelial cells and whether the decrease in Wnt / β-catenin signaling is related to ischemic femoral head necrosis.
[0021] Zinc-finger E-box-binding homeobox-1 (ZEB1) is involved in wound healing, fibrosis, migration and invasion, and is essential for growth and development and a series of pathological conditions, and is associated with poor clinical prognosis in most human cancers. In triggering the transformation of epithelial cells to mesenchymal cells, ZEB1 not only directly inhibits the transcription of many epithelial-specific markers involved in cell adhesion and differentiation, such as cadherins, tight and gap junction proteins, but also activates mesenchymal genes such as laminin and urokinase plasminogen activator. Studies have found that ZEB1 and TCF-4 regulate transcriptional activity of each other, thereby regulating the expression of Wnt target genes. In addition, ZEB1 can also prevent skeletal muscle from The latest studies have shown that ZEB1 is mainly expressed in H-type vascular endothelial cells in the bones of humans and mice, and endothelial cell-specific deletion of ZEB1 inhibits H-type angiogenesis and bone formation, but does not affect angiogenesis in non-bone tissues. Upregulating the expression of ZEB1 in osteoporotic mice can regulate skeletal endothelial cells, thereby promoting angiogenesis-dependent osteogenesis. Therefore, ZEB1 can activate the Wnt / β-catenin pathway to regulate the occurrence of the disease, but it is unclear whether ZEB1 in H-type endothelial cells regulates angiogenesis-dependent osteogenesis through the Wnt / β-catenin signaling pathway.
[0022] Through the above research, we found that bone formation and balance are jointly regulated by a special vascular environment, multiple growth factors, hormones, multiple signals and biomechanics, among which the role of blood vessels is crucial. Abnormal vascular function will lead to bone failure. Therefore, we propose the following research hypothesis: The decrease of ZEB1 will damage the Wnt / β-catenin signaling pathway, thereby affecting the expression of H-type blood vessels and vascular-osteogenesis coupling, and ultimately participating in the occurrence of steroid-induced femoral head necrosis (SONFH). We will explore the effect of ZEB1 on the H-type blood vessels of the femoral head, the vascular-osteogenesis coupling process and the expression of the Wnt / β-catenin signaling pathway in SONFH, so as to reveal the pathogenesis of SONFH and provide a theoretical basis for drug intervention in SONFH.
[0023] In summary: The present invention proposes a new viewpoint that "femoral head necrosis is related to bone formation disorder dependent on H-type vascular endothelial cells". Previous studies on ischemic femoral head necrosis have not delved into the key issue of "H-type blood vessels" and the vascular-osteogenesis coupling in which they participate. This study uses H-type blood vessels as the entry point, and promotes bone formation dependent on it by activating related pathways of ZEB1 highly expressed in H-type blood vessels, attempting to prevent the occurrence and progression of femoral head necrosis. This will point out new research ideas and directions for future research in this discipline and in the field of research, and provide new solutions for the treatment of ischemic femoral head necrosis. No research has been found on how ZEB1 activates the Wnt / β-catenin pathway to promote H The purpose of this study is to report on the role and molecular mechanism of type H vascular dependent osteogenesis in protecting ischemic femoral head necrosis. This experiment comprehensively applied human femoral head specimen detection and animal experiments to conduct experiments both in vivo and in vitro, and used gene knockdown, liposome transfection and other technical interventions to reasonably group animals. The expression of ZEB1, Wnt, Runx2 / Osterix / ALP, VEGF, H-type vascular endothelial cell CD31, and EMCN was located and quantitatively analyzed by immunofluorescence double labeling and multiple labeling techniques. The above techniques and methods confirmed that ZEB1 was highly expressed in H-type vascular endothelial cells of the femoral head, clarifying the therapeutic effect of ZEB1 on femoral head necrosis by regulating the Wnt / β-catenin pathway to mediate vascular-osteogenesis coupling.
Claims
1. The therapeutic effect of activating ZEB1 on steroid-induced femoral head necrosis is characterized by: The steps include: S1: Collection: Femoral heads of SONFH and femoral neck fracture patients were collected and decalcified for immunofluorescence staining to compare the expression of ZEB1 and H-type blood vessels in the femoral heads of SONFH patients and femoral neck fracture patients; S2: Model construction: construct a SONFH mouse animal model and set up a blank control group; S3: Detection: Based on the successful construction of the SONFH mouse model, cationic liposome transfection technology was used to overexpress ZEB1 in SONFH mice to further detect the expression of ZEB1, H-type blood vessels, angiogenic and osteogenic ability, and Wnt / β-catenin signaling pathway.
2. The therapeutic effect of activated ZEB1 on steroid-induced femoral head necrosis according to claim 1, characterized in that: In the S2 step, based on the successful construction of the SONFH mouse model, ZEB1 was knocked down using lentiviral infection technology to further detect the expression of ZEB1, H-type blood vessels, vascular osteogenic coupling levels, and the Wnt / β-catenin signaling pathway.
